Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04917289Phase 3Not yet recruiting
Phase 3, randomised, open-label trial in colorectal cancer (CRC) (2 arms), sponsored by Fudan University. Primary endpoint: Overall Survival at 3 years. Planned start Jun 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04917289.